MENU
NEXI
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

NexImmune (NEXI) Ownership - Who owns NexImmune?

NexImmune Inc is a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the body’s T cells to generate an antigen-specific cell-mediated immune response with curative potential for the patient... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
348.67K
P/E Ratio
N/A
Total Cash
2.42M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
2.07
Dividend Yield
N/A
Total Cash/Share
1.74
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details